Free tool
FAERS Monitor: Marinol
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 018651 or its brand name (Marinol, Dronabinol). Reports on generic versions are filed under their own applications.
Reports
8,051
Serious
6,027
75% of reports
Hospitalization
3,111
Death reported
1,678
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- nausea901
- fatigue716
- diarrhoea619
- death599
- vomiting589
- off label use523
- decreased appetite455
- pain442
- weight decreased421
- dyspnoea387
- asthenia383
- toxicity to various agents353
- drug ineffective323
- headache321
- drug abuse313
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 89 |
| 2005 | 84 |
| 2006 | 121 |
| 2007 | 108 |
| 2008 | 76 |
| 2009 | 102 |
| 2010 | 129 |
| 2011 | 150 |
| 2012 | 181 |
| 2013 | 233 |
| 2014 | 293 |
| 2015 | 429 |
| 2016 | 518 |
| 2017 | 557 |
| 2018 | 664 |
| 2019 | 724 |
| 2020 | 662 |
| 2021 | 542 |
| 2022 | 517 |
| 2023 | 574 |
| 2024 | 562 |
| 2025 | 462 |
| 2026 | 274 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,046,108 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| drug abuseSignal | 313 | 9.9 | 8.8 | 2,482 |
| toxicity to various agentsSignal | 353 | 5.5 | 4.9 | 1,295 |
| decreased appetiteSignal | 455 | 5.1 | 4.7 | 1,521 |
| weight decreasedSignal | 421 | 3.9 | 3.6 | 933 |
| vomitingSignal | 589 | 3.3 | 3.0 | 949 |
| nauseaSignal | 901 | 3.0 | 2.8 | 1,225 |
| astheniaSignal | 383 | 2.7 | 2.4 | 403 |
| diarrhoeaSignal | 619 | 2.5 | 2.3 | 576 |
| fatigueSignal | 716 | 2.4 | 2.2 | 608 |
| pain | 442 | 1.9 | 1.7 | 187 |
| death | 599 | 1.8 | 1.7 | 228 |
| dyspnoea | 387 | 1.8 | 1.6 | 137 |
| off label use | 523 | 1.6 | 1.4 | 109 |
| headache | 321 | 1.3 | 1.2 | 28 |
| drug ineffective | 323 | 0.6 | 0.6 | 69 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.